Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making
Breast cancer is the most common cancer in women, impacting 2.1 million women each year. The number of publications on BC is much higher than for any other type of tumor, as well as the number of clinical trials. One of the consequences of all this information is reflected in the number of approved...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/11/12/1348 |
_version_ | 1797503133221388288 |
---|---|
author | Tatiana Martins Tilli |
author_facet | Tatiana Martins Tilli |
author_sort | Tatiana Martins Tilli |
collection | DOAJ |
description | Breast cancer is the most common cancer in women, impacting 2.1 million women each year. The number of publications on BC is much higher than for any other type of tumor, as well as the number of clinical trials. One of the consequences of all this information is reflected in the number of approved drugs. This review aims to discuss the impact of technological advances in the diagnosis, treatment and decision making of breast cancer and the prospects for the next 10 years. Currently, the literature has described personalized medicine, but what will the treatment be called for in the coming years? |
first_indexed | 2024-03-10T03:46:10Z |
format | Article |
id | doaj.art-aea78804e55b46bfbed6e6ea1f30df96 |
institution | Directory Open Access Journal |
issn | 2075-4426 |
language | English |
last_indexed | 2024-03-10T03:46:10Z |
publishDate | 2021-12-01 |
publisher | MDPI AG |
record_format | Article |
series | Journal of Personalized Medicine |
spelling | doaj.art-aea78804e55b46bfbed6e6ea1f30df962023-11-23T09:08:18ZengMDPI AGJournal of Personalized Medicine2075-44262021-12-011112134810.3390/jpm11121348Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision MakingTatiana Martins Tilli0Translational Oncology Platform, Center for Technological Development in Health, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, BrazilBreast cancer is the most common cancer in women, impacting 2.1 million women each year. The number of publications on BC is much higher than for any other type of tumor, as well as the number of clinical trials. One of the consequences of all this information is reflected in the number of approved drugs. This review aims to discuss the impact of technological advances in the diagnosis, treatment and decision making of breast cancer and the prospects for the next 10 years. Currently, the literature has described personalized medicine, but what will the treatment be called for in the coming years?https://www.mdpi.com/2075-4426/11/12/1348breast cancerprecision medicinetechnologydiagnosistreatment |
spellingShingle | Tatiana Martins Tilli Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making Journal of Personalized Medicine breast cancer precision medicine technology diagnosis treatment |
title | Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making |
title_full | Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making |
title_fullStr | Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making |
title_full_unstemmed | Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making |
title_short | Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making |
title_sort | precision medicine technological impact into breast cancer diagnosis treatment and decision making |
topic | breast cancer precision medicine technology diagnosis treatment |
url | https://www.mdpi.com/2075-4426/11/12/1348 |
work_keys_str_mv | AT tatianamartinstilli precisionmedicinetechnologicalimpactintobreastcancerdiagnosistreatmentanddecisionmaking |